Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Assessing the comparative value of sedatives in the intensive care unit.

Publication ,  Journal Article
Cox, CE; Govert, JA
Published in: Crit Care Med
February 2010

Duke Scholars

Published In

Crit Care Med

DOI

EISSN

1530-0293

Publication Date

February 2010

Volume

38

Issue

2

Start / End Page

709 / 711

Location

United States

Related Subject Headings

  • Respiration, Artificial
  • Midazolam
  • Long-Term Care
  • Intensive Care Units
  • Hypnotics and Sedatives
  • Humans
  • Emergency & Critical Care Medicine
  • Dexmedetomidine
  • Critical Care
  • Cost-Benefit Analysis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cox, C. E., & Govert, J. A. (2010). Assessing the comparative value of sedatives in the intensive care unit. Crit Care Med, 38(2), 709–711. https://doi.org/10.1097/CCM.0b013e3181bfeaf7
Cox, Christopher E., and Joseph A. Govert. “Assessing the comparative value of sedatives in the intensive care unit.Crit Care Med 38, no. 2 (February 2010): 709–11. https://doi.org/10.1097/CCM.0b013e3181bfeaf7.
Cox CE, Govert JA. Assessing the comparative value of sedatives in the intensive care unit. Crit Care Med. 2010 Feb;38(2):709–11.
Cox, Christopher E., and Joseph A. Govert. “Assessing the comparative value of sedatives in the intensive care unit.Crit Care Med, vol. 38, no. 2, Feb. 2010, pp. 709–11. Pubmed, doi:10.1097/CCM.0b013e3181bfeaf7.
Cox CE, Govert JA. Assessing the comparative value of sedatives in the intensive care unit. Crit Care Med. 2010 Feb;38(2):709–711.

Published In

Crit Care Med

DOI

EISSN

1530-0293

Publication Date

February 2010

Volume

38

Issue

2

Start / End Page

709 / 711

Location

United States

Related Subject Headings

  • Respiration, Artificial
  • Midazolam
  • Long-Term Care
  • Intensive Care Units
  • Hypnotics and Sedatives
  • Humans
  • Emergency & Critical Care Medicine
  • Dexmedetomidine
  • Critical Care
  • Cost-Benefit Analysis